baber/WOPTO huggingface dataset:
Patent NZ-334879-A (NZ)
Title: A method of in vivo protein synthesis comprising initiating translation with an amino acid other than methionine
Inventor: RAJBHANDARY UTTAM L
IPC: C07K14/61
Filed: 1997-08-28
Abstract: A method of overproducing, in a prokaryotic host cell, a protein which is initiated with an amino acid other than methionine, in which methionyl-tRNA transformylase and, optionally, the appropriate tRNA synthetase are overexpressed, comprising the steps of: 1) Introducing into the prokaryotic host cell;  a) DNA which encodes the protein and which has an initiator codon for an amino acid other than methionine;  b) DNA which encodes a mutant initiator tRNA containing the corresponding anti-codon; and  c) DNA encoding methionyl-tRNA transformylase, thereby producing modified prokaryotic host cells; and 2) Maintaining the modified prokaryotic host cells under conditions appropriate for overproduction of the methionyl tRNA transformylase and expression of the DNA which encodes the protein and has an initiator codon for an amino acid other than methionine, wherein the protein which is initiated with valine, isoleucine or phenylalanine.
Patent NZ-335767-A (NZ)
Title: Methods and apparatus for translating between languages
Inventor: CHERNY JULIUS
IPC: G06F17/28
Filed: 1997-10-16
Abstract: Methods and apparatus for performing translation between different language are provided. The present invention includes a translation system that performs translation having increased accuracy by providing a three-dimensional topical dual-language database. The topical database includes a set of source-to-target language translations for each topic that the database is being used for. In one embodiment, a user first selects the topic of conversation, then words spoken into a telephone are translated and produced as synthesized voice signals from another telephone so that a near real-time conversation may be had between two people speaking different languages. An additional feature of the present invention is the addition of a computer terminal that displays the input and output phrases so that either user may edit the input phrases, or indicate that the translation was ambiguous and request a rephrasing of the material.
Patent NZ-336255-A (NZ)
Title: Measuring current in AC circuit using transformer with two secondary windings with one being short circuited
Inventor: LAU CHI-SANG
IPC: G01R15/18
Filed: 1999-06-11
Abstract: An alternating current measuring device comprises: a) an iron core made of high permeability material; b) an input current winding having a predetermined number of turns of conductor winding around the iron core and connected in series with an alternating current circuit to be measured and c) a secondary winding comprising an output current winding and a measuring winding The output current winding has at least one turn of conductor winding around the iron core and two ends connected together and is short circuited.  The output current winding has a closed contour and is made of homogeneous material with low temperature coefficient and high stability. The measuring winding has a predetermined number of turns of conductor winding around the iron core and two ends open circuited for connecting to a voltage meter for measuring an induced voltage thereon. The input resistance of the voltage meter is high while a current flowing in the measuring winding is small.  The measuring winding remains in nearly open circuit even after the voltage meter is connected thereto.  The alternating current circuit to be measured is connected to the input current winding. A secondary current almost entirely flows in the output current winding in such a manner that the secondary current flowing in the output current winding counteracts completely a magneto motive force of the input current winding while the measuring winding carries negligibly small current, therefore a voltage induced by the secondary current can be measured by the voltage meter.
Patent NZ-336341-A (NZ)
Title: 17alpha-dihydroequilenin or salts of 17alpha-dihydroequilenin-3-sulfate ester for use as a medical antioxidant
Inventor: ADELMAN STEVEN JAY
IPC: A61P35/00
Filed: 1997-12-05
Abstract: 17á-dihydroquilenin-3-sulfate ester for use in inhibiting or treating a free radical induced disease state.  Such conditions that require inhibition of endogenous free radicals include cancers, central nervous system disorders, Alzheimer's disease, bone disease, aging inflammatory disorders, peripheral vascular disease, rheumatoid arthritis, autoimmune diseases, respiratory distress, emphysema, prevention or reperfusion injury, viral hepatitis, chronic active hepatitis, tuberculosis, psoriasis, systemic lupus erythematosus, adult respiratory distress syndrome, central nervous system trauma and stroke, or injury during reperfusion procedures.
Patent NZ-501208-A (NZ)
Title: An apparatus for cleaning synthetic grass
Inventor: ALLAWAY ALLAN WILLIAM
IPC: A47L5/24
Filed: 1998-05-15
Abstract: An apparatus for cleaning synthetic grass comprises a frame including a brush means 20 for brushing a ground surface, a suction means 26 connected to a particle collection zone located at the periphery of the brush means and a driving means 22 connected to brush means 20 and operable to activate the brush means to brush a surface to dislodge particulate matter whereby the suction means can suck up waste matter from the particulate matter.
Patent NZ-502796-A (NZ)
Title: Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
Inventor: GALLOWAY SUSAN MAY
IPC: C07K16/22
Filed: 2000-06-15
Abstract: Nucleotide and amino acid sequences relating to GDF-9B of oocyte factors for altering ovarian follicular growth in vivo or in vitro. Homodimeric and heterodimeric polypeptides and their use for altering mammalian ovarian follicular growth in vivo and in vitro are also described.
Patent NZ-503995-A (NZ)
Title: Indazole compounds, and pharmaceutical compositions and uses thereof, based on indazole bioisostere replacement of catechol in PDE4 inhibitors
Inventor: MARFAT ANTHONY
IPC: A61K31/517
Filed: 1998-10-09
Abstract: Therapeutically active compositions of matter are described which are useful for treating or preventing diseases and conditions comprising inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis, and pulmonary emphysema; infectious diseases including endotoxic shock and toxic shock syndrome; immune diseases including systemic lupus erythematosis and psoriasis; and other diseases including bone resorption diseases and reperfusion injury; wherein the composition of matter comprises a compound which is an inhibitor of phosphodiesterase isozyme 4 (PDE4) and wherein an indazole is one essential component of the compound's overall chemical structure, and wherein the indazole constitutes a bioisosteric replacement of a catechol component or functional derivative thereof in a known compound having the same therapeutic activity and the same remaining components of its overall chemical structure. Included are compounds of Formula (IA) or (IB), wherein R2a and R2b are independently selected from the group consisting essentially of hydrogen and hereinafter recited substituents, provided that one, but not both of R2a and R2b must be independently selected as hydrogen, wherein said substituents comprise moieties including the following: (IC), (ID), (IE), (IF), (IIA), (IIB), (IIC), (IID), (IIE), (IIF), (IIG), (IIH), (III), (IIIA), (IIIB), (IIIC), (IIID), (IIIE), (IIIF), (IIIG), (IIIH), (IIII), (IIIJ), (IIIK), (IIIL), (IIIM), (IIIN), (IIIO), (IIIP), (IIIQ), (IIIR), (IIIS), (IIIT), (IV), (VA), (VB), (VC), (VD), (VEa), (VE), (VF), (VG), (VH), (VI), (VJ), (VK), (VL), (VM) as described in the specification.
Patent NZ-505073-A (NZ)
Title: Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases
Inventor: SJOQUIST GABRIELLE
IPC: A61P29/00
Filed: 1998-12-22
Abstract: A pharmaceutical composition comprising micelles in an aqueous medium, where the micelles comprise a lipophilic glucocorticosteroid and one and only one pharmaceutically acceptable surfactant. The compositions described above are useful for treating allergic and/or inflammatory diseases in the respiratory tract.
Patent NZ-510224-A (NZ)
Title: Data input device using coordinate system defined by refracted infra-red light grid
Inventor: CLIFFORD LEONARD EDWARD PATRIC
IPC: G02B26/08
Filed: 2001-03-01
Abstract: An input device for a processing system comprising a transparent sheet (3) to which refracting strips (4) are attached. The refracting strips (4) define a rectangular boundary. Behind the transparent sheet (3) adjacent to the refracting strips (4) are transmitting (1) and receiving (2) Light Emitting Diodes (LED's). The light from a transmitting LED (1) travels through the transparent sheet (3) into the refracting strip (4), across the opposite face of the transparent sheet (3) into the cooperating refracting strip (4) back through the transparent sheet (3) and into the receiving LED (2). The LED pairs are arranged to form a grid pattern so that breaking of two perpendicular beams defines a coordinate, which is processed by a device to perform a desired function.
Patent NZ-511030-A (NZ)
Title: Method and device for opening and filling pre-manufactured bag packages
Inventor: DOMANSKY PHILIPPE
IPC: B65B43/26
Filed: 1999-09-16
Abstract: A method for opening pre-fabricated pouches, bag packages or pouches (5) and subsequently filling the pouches is disclosed.  Each pouch has a circumferential seal and an opening zone. The method comprises the following steps: a) introducing a pouch (5) into a vacuum chamber (8), which has a first opening (9) facing the opening zone of the pouch and which is connected to the environment, as well as a second opening (10) remote from the opening zone; b) sucking air out of the vacuum chamber through the second opening, with a volume flow adequate for producing in the vacuum chamber a vacuum with respect to the environment, through which the pouch is opened; d) moving out the support with the pouch held thereon out of the vacuum chamber, characterized in that, during steps a) to c), the pouch (5) is held on a support (1).
Patent NZ-515529-A (NZ)
Title: Benzene derivatives, preparation method and pharmaceutical compositions containing same
Inventor: BOIGEGRAIN ROBERT
IPC: A61P9/00
Filed: 2000-06-08
Abstract: Benzene derivatives of formula (I) comprising an amine function substituted with an alkyl group and a cycloalkyl group, which specifically bind to sigma receptors, particularly those of the peripheral nervous system. Compounds are useful for the treatment of autoimmune disorders and combating the proliferation of tumor cells.
Patent NZ-522146-A (NZ)
Title: Mammalian receptor-like proteins, designated DNAX cytokine receptor subunits (DCRS), in particular DCRS5
Inventor: CHIRICA MADALINE
IPC: A61K38/08
Filed: 2001-05-10
Abstract: Receptors related to cytokine receptors, e.g., primate, cytokine receptor-like molecular structures, designated DNAX Cytokine Receptor Subunits (DCRS), and their biological activities are described; description of one subunit, designated DCRS5 in particular. The description includes nucleic acids encoding the polypeptides themselves and methods for their production and use. The nucleic acids are characterised, in part, by their homology to cloned complementary DNA (cDNA) sequences enclosed herein. Additionally provided is matching of the p40/IL-B30 ligand with receptor subunits DCRS5 and IL-12Râ1, which pairing provides insight into indications for use of the agonists and antagonists based upon reagents directed thereto. Also provided is a substantially pure or recombinant polypeptide comprising at least ten contiguous amino acids of the intracellular portion of SEQ ID NO: 2.
Patent NZ-524845-A (NZ)
Title: Punnet
Inventor: JOHN KEVIN GARELJA
IPC: B65D21/00
Filed: 2003-03-20
Abstract: A punnet defined by walls, the walls including side walls, the side walls being substantially in the shape of a trapezium having truncated ends. The walls are configured so that when pluralities of punnets are positioned in a larger container, the punnets will tend to position themselves to minimize relative movement between the panels in the container.
Patent NZ-526074-A (NZ)
Title: Triboelectric system
Inventor: BROWN COLIN W
IPC: D06M10/00
Filed: 2001-12-05
Abstract: A method and system for inducting an electric charge in a cleaning sheet for cleaning and removing particles from a surface are disclosed. The system includes a cleaning sheet (10) for collecting and retaining the particles and a charging surface (50) configured to frictionally engage the sheet (10). The cleaning sheets (10) typically have a basis weight of at least about 30 g/m2. The system may include a container (40) for housing and dispensing the cleaning sheet (10). When the sheet (10) is passed across the charging surface (50), the electrical charge in the sheet (10) is generally increased by at least about 500 V.
Patent NZ-531796-A (NZ)
Title: Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment of hyperlipidaemia
Inventor: STARKE INGEMAR
IPC: C07K/
Filed: 2002-09-05
Abstract: Compounds of formula (I), pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia are disclosed, wherein Rv, Rx, Ry, Rz, v, M, R1, R2, R3, R4, R5 and R6 are as defined in the specification. Processes for their manufacture and pharmaceutical compositions containing them are also disclosed.
Patent NZ-539631-A (NZ)
Title: Novel phenylnapthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
Inventor: POISSONNIER-DURIEUX SOPHIE
IPC: A61P9/10
Filed: 2003-11-04
Abstract: Phenylnapthalene derivative compounds of formula (I) are disclosed, wherein the variables are as defined in the specification. Also disclosed are pharmaceutical compositions of the compounds of formula (I) for use in the manufacture of medicaments for the treatment of sleep disorders, stress, anxiety, seasonal affective disorders or severe depression, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue due to jetlag, schizophrenia, panic attacks, melancholia, appetite disorders, obesity, insomnia, psychotic disorders, epilepsy, diabetes, Parkinson's disease, senile dementia, various disorders associated with normal or pathological ageing, migraine, memory losses, Alzheimer's disease, cerebral circulation disorders, and also sexual dysfunctions, and as inhibitors of ovulation, immunomodulators and in the treatment of cancers.
Patent NZ-540221-A (NZ)
Title: Systems and methods for extensions and inheritance for units of information manageable by a hardware/software interface system
Inventor: DEMIROSKI BEKIM
Filed: 2004-07-29
Abstract: Systems and methods for extensions of units of information manageable by a hardware/software interface system are described. The method comprises the steps of: defining an initial discrete storable unit of information having a type structure; defining an extension representative of a desired additional data structure; attaching the extension to the type structure of the initial discrete storable unit of information; and,creating a new discrete storable unit of information.
Patent NZ-542552-A (NZ)
Title: Method for treating recycled polyethylene terephthalate containing melting contaminants
Inventor: HAYWARD DONALD W
IPC: B29B17/04
Filed: 2004-03-12
Abstract: Disclosed is a process for treating RPET flakes comprising providing a quantity of RPET flakes having melting contaminants, comminuting the RPET flakes to prepare RPET particles having an average mean particle size less than about 300 microns, melting the RPET particles to prepare an RPET melt, and mixing the RPET melt.
Patent NZ-544210-A (NZ)
Title: Signal transmitting cable
Inventor: BROWN GEORGE HENRY PLATT
IPC: G02B6/44
Filed: 2003-06-26
Abstract: A cable assembly that includes a plurality of flexible signal transmitting members 2 is disclosed. The cable is arranged so that the signal transmitting members 2 are surrounded by a first layer 3 that restricts movement between at least the outermost members of the bundle. An outermost thermoplastic polymer layer 4 surrounds the first layer, and has a thickness of less than 400 microns around at least 10% of the circumference of the cable assembly.
Patent NZ-545667-A (NZ)
Title: Shower apparatus where the water supply is inside the shower post and connected to the mixer and shower rose through the post
Inventor: GODFREY BARRY JOHN
Filed: 2006-09-02
Abstract: A method of constructing a shower apparatus in a room is disclosed. The method includes: A) providing a hollow shower post (1) that has a control valve (2) and a shower rose (3) fixed to it. The shower post encloses the water supply that supplies water to the valve (2) and the water supply between the valve (2) and the shower rose (3), and B) fixing the ends of the post to substantially opposing surfaces of the room. Water is fed to the post through one of the opposing surfaces of the room.
Patent NZ-553390-A (NZ)
Title: Nutritional composition comprising indigestible oligosaccharides
Inventor: BOEHM GUNTHER
IPC: A23L33/00
Filed: 2005-08-24
Abstract: Provided is the use of indigestible oligosaccharides and digestible galactose saccharide for the manufacture of a composition for oral administration for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, in a mammal, including infants and children, said composition comprising a) a galactose containing indigestible oligosaccharide containing at least two terminal saccharide units, wherein at least one terminal saccharide unit is selected from the group consisting of glucose and galactose; and at least one terminal saccharide is selected from the group consisting of galactose and fucose; and b) at least 5 wt.% digestible galactose saccharide based on total dry weight of the composition, said saccharide being selected from the group consisting of galactose and digestible galactose containing saccharide containing at least two terminal saccharide units, wherein at least one terminal saccharide unit is selected from the group consisting of glucose and galactose; and at least one terminal saccharide is selected from the group consisting of galactose and fucose.
Patent NZ-556577-A (NZ)
Title: Method of controlling access to an elevator car
Inventor: VOGL WOLFGANG
Filed: 2007-07-18
Abstract: A method of providing access to an elevator car (5) for inspection or maintenance is disclosed. A landing door (T4) of the elevator shaft (1) is opened and the elevator control is switched into a maintenance mode which controls the car to travel to a predetermined stop position in order to give access to the car, particularly the ceiling or underside of the car. The maintenance mode is entered by operating a landing call button (10) in a particular identification pattern.
Patent NZ-561923-A (NZ)
Title: A portal apparatus and method for its use
Inventor: IVANINE SERGUEI
IPC: A01M13/00
Filed: 2006-03-01
Abstract: A fumigation chamber portal apparatus for use with a fumigation chamber that at least in part incorporates a flexible canopy, a fumigation assembly, a fumigation system, a method of installing a fumigant gas port, and a method of fumigating a product, are disclosed. The portal apparatus is adapted to be seated on an underlying structure and is arranged to be positioned between the canopy and the underlying structure. The portal apparatus includes a barrier, a gas inlet and/or outlet pipe, and a sealing surface. The barrier has an enlarged central portion that tapers off towards thin edge portions. The gas inlet pipe and/or a gas outlet pipe passes entirely through the barrier whilst maintaining a gastight seal across the barrier such that, in use, the pipe allows the flow of fumigant into or out of the fumigation chamber. The sealing surface extends along an outer periphery of the barrier between the opposite edge portions. The sealing surface is adapted to be contactable with the flexible canopy to provide a gas-tight seal between the apparatus and the canopy.
Patent NZ-562223-A (NZ)
Title: Pharmaceutical composition comprising lapatinib or N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]4-quinazolinamine
Inventor: CARTER BARRY HOWARD
IPC: A61K9/20
Filed: 2006-04-18
Abstract: Disclosed is an oral pharmaceutical composition comprising: (i) N-{3-Chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl] amino}methyl)-2-furyl]-4-quinazolinamine (lapatinib) ditosylate monohydrate in a range of 42 to 48 percent by weight; (ii) povidone in a range of 5.5 to 7.5 percent by weight; (iii) sodium starch glycolate in a range of 3.5 to 5.5 percent by weight; (iv) microcrystalline cellulose in a range of 40 to 46 percent by weight; and (v) magnesium stearate in a range of 0.8 to 1.2 per cent by weight. Also disclosed is an oral pharmaceutical composition comprising: (i) N-{3-Chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl] amino}methyl)-2-furyl]-4-quinazolinamine (lapatinib) ditosylate monohydrate in a range of 30 to 47 percent by weight; (ii) povidone in a range of 4 to 9 percent by weight; (iii) sodium starch glycolate in a range of 2 to 8 percent by weight; (iv) microcrystalline cellulose in a range of 35 to 50 percent by weight; (v) magnesium stearate in a range of 0.6 to 1.3 percent by weight; and (vi) a film coat in a range of 2.5 to 3.5 percent by weight.
Patent NZ-575499-A (NZ)
Title: System and method for adaptive non-uniformity compensation for a focal plane array
Inventor: KILGORE PATRICK M
IPC: G06V10/30
Filed: 2007-06-08
Abstract: An imaging system (10) for a non line of sight launch system precision attack missile comprises a focal plane array (16) that generates an image signal; and a video processing assembly (24) that reduces an amount of fixed pattern noise from the image signal by applying a recursively updated offset term to each non-defective pixel in the image signal to generate a corrected image signal. The video processing assembly recursively updates the offset correction terms by spatially filtering the corrected image signal for a current frame of the corrected image signal by applying a median filter to each pixel of the current frame and applying an anti-mean filter to the output of the median filter to generate a filtered corrected frame of the corrected image signal; comparing the filtered corrected current frame with a spatially filtered corrected preceding frame of the corrected image signal. The spatially filtered corrected preceding frame is generated by applying the median filter to each non-defective pixel of the preceding frame of the corrected image signal and applying the anti-mean filter to the output of the median filter for the corrected image signal of the preceding frame. The preceding frame and the current frame are sequential image frames of the corrected image signal that have different scene registration by movement of the image sensor. The offset correction terms with terms generated as a function of the comparison are then updated. The median filter removes noise in the form of outlying pixels that could bias operation of the anti-mean filter, and the anti-mean filter computes a difference between the average value of the pixels surrounding the pixel that is being processed and the value of the pixel that is being processed. The corrected image signal is outputted to a target tracking system (30) of the missile.